Eli Lilly stock surges as cheaper drugs unlock a bigger market
For many years, a major barrier to popular weight-loss medications has been straightforward: although millions of Americans may want them, many cannot afford them. Eli Lilly (LLY) is beginning to demonstrate what occurs when that barrier is removed. More than 500,000 people have joined a Medicare pilot offering eligible older adults and people with disabilities

